Direct exosome stimulation of peripheral human T cells detected by ELISPOT

被引:249
作者
Admyre, Charlotte [1 ]
Johansson, Sara M.
Paulie, Staffan
Gabrielsson, Susanne
机构
[1] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Unit Clin Allergy Res, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden
[3] Stockholm Univ, Dept Immunol, Stockholm, Sweden
关键词
dendritic cells; ELISPOT exosomes; IFN-gamma; T cells;
D O I
10.1002/eji.200535615
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Exosomes from APC are nano-vesicles that can induce antigen-specific T cell responses and are presently explored as therapeutic tools in different clinical settings. Investigations of the capacity of exosomes to stimulate T cells in vitro have mostly been performed on T cell hybridomas, clones or lines. Whether exosomes can stimulate T cells directly or need the presence of dendritic cells (DC) is debated. We could detect exosome-induced antigen-specific CD8(+) T cell responses in peripheral blood from humans. Exosomes from monocyte-derived DC (MDDC) were loaded with a mix of 23 immunogenic peptides from EBV, CMV and influenza virus, and added to autologous peripheral CD8(+) T cells. IFN-gamma-producing cells were detected by enzyme-linked immunospot assay (ELISPOT). MDDC-exosomes induced IFN-gamma production in CD8(+) T cells without addition of DC. The response was exosome dose dependent, and dependent on exosomal MHC class I. Furthermore, we detected an enhanced T cell stimulatory capacity by exosomes from lipopolysaccharide-matured MDDC compared to exosomes from immature MDDC. Exosomes could also induce TNF-alpha production. These results show, for the first time, that exosomes can directly stimulate human peripheral CD8(+) T cells in an antigen-specific manner and that ELISPOT is a suitable method for detecting exosome-induced peripheral T cell responses. This system may provide a useful tool when developing exosomes as therapeutic agents.
引用
收藏
页码:1772 / 1781
页数:10
相关论文
共 33 条
[11]
Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry [J].
Clayton, A ;
Court, J ;
Navabi, H ;
Adams, M ;
Mason, MD ;
Hobot, JA ;
Newman, GR ;
Jasani, B .
JOURNAL OF IMMUNOLOGICAL METHODS, 2001, 247 (1-2) :163-174
[12]
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays [J].
Currier, JR ;
Kuta, EG ;
Turk, E ;
Earhart, LB ;
Loomis-Price, L ;
Janetzki, S ;
Ferrari, G ;
Birx, DL ;
Cox, JH .
JOURNAL OF IMMUNOLOGICAL METHODS, 2002, 260 (1-2) :157-172
[13]
Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface [J].
Denzer, K ;
van Eijk, M ;
Kleijmeer, MJ ;
Jakobson, E ;
de Groot, C ;
Geuze, HJ .
JOURNAL OF IMMUNOLOGY, 2000, 165 (03) :1259-1265
[14]
Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes [J].
Escola, JM ;
Kleijmeer, MJ ;
Stoorvogel, W ;
Griffith, JM ;
Yoshie, O ;
Geuze, HJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (32) :20121-20127
[15]
Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes:: results of thefirst phase I clinical trial [J].
Escudier, B ;
Dorval, T ;
Chaput, N ;
André, F ;
Caby, MP ;
Novault, S ;
Flament, C ;
Leboulaire, C ;
Borg, C ;
Amigorena, S ;
Boccaccio, C ;
Bonnerot, C ;
Dhellin, O ;
Movassagh, M ;
Piperno, S ;
Robert, C ;
Serra, V ;
Valente, N ;
Le Pecq, JB ;
Spatz, A ;
Lantz, O ;
Tursz, T ;
Angevin, E ;
Zitvogel, L .
JOURNAL OF TRANSLATIONAL MEDICINE, 2005, 3 (1)
[16]
Exosomes as a tumor vaccine: Enhancing potency through direct loading of antigenic peptides [J].
Hsu, DH ;
Paz, P ;
Villaflor, G ;
Rivas, A ;
Mehta-Damani, A ;
Angevin, E ;
Zitvogel, L ;
Le Pecq, JB .
JOURNAL OF IMMUNOTHERAPY, 2003, 26 (05) :440-450
[17]
Direct stimulation of naive T cells by membrane vesicles from antigen-presenting cells: Distinct roles for CD54 and B7 molecules [J].
Hwang, IY ;
Shen, XF ;
Sprent, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (11) :6670-6675
[18]
Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO
[19]
2-I
[20]
A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer [J].
Morse, MA ;
Garst, J ;
Osada, T ;
Khan, S ;
Hobeika, A ;
Clay, TM ;
Valente, N ;
Shreeniwas, R ;
Sutton, MA ;
Delcayre, A ;
Hsu, DH ;
Le Pecq, JB ;
Lyerly, HK .
JOURNAL OF TRANSLATIONAL MEDICINE, 2005, 3 (1)